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Abstract
Background: The complexity of the skeletal muscle and the identification of numerous human disease-causing
mutations in its constitutive proteins make it an interesting tissue for proteomic studies aimed at understanding
functional relationships of interacting proteins in both health and diseases.
Method: We undertook a large-scale study using two-hybrid screens and a human skeletal-muscle cDNA library to
establish a proteome-scale map of protein-protein interactions centered on proteins involved in limb-girdle
muscular dystrophies (LGMD). LGMD is a group of more than 20 different neuromuscular disorders that principally
affect the proximal pelvic and shoulder girdle muscles.
Results and conclusion: The interaction network we unraveled incorporates 1018 proteins connected by 1492
direct binary interactions and includes 1420 novel protein-protein interactions. Computational, experimental and
literature-based analyses were performed to assess the overall quality of this network. Interestingly, LGMD proteins
were shown to be highly interconnected, in particular indirectly through sarcomeric proteins. In-depth mining of
the LGMD-centered interactome identified new candidate genes for orphan LGMDs and other neuromuscular
disorders. The data also suggest the existence of functional links between LGMD2B/dysferlin and gene regulation,
between LGMD2C/γ-sarcoglycan and energy control and between LGMD2G/telethonin and maintenance of
genome integrity. This dataset represents a valuable resource for future functional investigations.
Keywords: Interactome, Muscular dystrophies, Yeast-two hybrid
Background
The skeletal muscle tissue with its movement generation
capacity is the organ of voluntary action but it plays also
a major role in metabolic homeostasis. It is composed of
long multinucleated cells, the myofibers, which possess a
highly structured organization to ensure the dynamics
and coordination of muscle contraction and resistance
to resulting physical stresses. Notwithstanding its very
well organized structure, the muscular tissue presents an
important plasticity, which is necessary for adaptation to
physical and metabolic constraints. These combined
characteristics of structure and plasticity depend on the
concerted action of protein complexes and of metabolic
and signaling pathways. These features together with the
complexity of the skeletal muscle organization and its
connection with human disorders makes it an interesting
tissue for proteomic studies aimed at understanding
functional relationships of interacting proteins in both
health and diseases.
During the last decade, an increasing number of stud-
ies have been carried out to produce and analyze large-
scale protein-protein interaction networks in various
bacterial and eukaryotic model systems. Several studies
have investigated the human interacting-proteins net-
work, either at a genome-wide scale [1-3] or with the
aim of exploring a targeted interaction network [4-6].
Remarkably, several disease-targeted projects have
proven to offer a very powerful strategy to address the
role and function of the proteins involved, as exemplified
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by Huntington’s disease [5] and in spinocerebellar ataxia
[6]. These works have capitalized on several high-
throughput technologies (yeast-two hybrid (Y2H) system
and Tandem Affinity Purification) to detect binary
protein-protein interactions (PPI) or protein complexes,
and have combined them with computational methods
to propose “interactome” networks.
As an approach towards the identification of skeletal
muscle functional networks, we undertook a large-scale
study to establish a proteome-scale map of protein-
protein interactions centered on proteins involved in
limb-girdle muscular dystrophies (LGMD). LGMD is a
group of neuromuscular disorders with autosomal dom-
inant (LGMD1) or recessive (LGMD2) inheritance
modes that principally affect the proximal pelvic and
shoulder girdle muscles (for a recent review see [7]).
More than twenty different genetic entities were identi-
fied so far but it is estimated that 30-40% of patients
clinically diagnosed with LGMD still do not have a gen-
etic signature of their disease [8] with at least 25% of
families who are not linked to any known locus and 40%
of isolated cases with no detected mutation in any
known LGMD gene. The known LGMD-causing genes
encode proteins expressed in a variety of cellular
compartments and involved in diverse biological
functions that are not yet fully understood. Yet, the
present knowledge has highlighted the importance of
the components of the dystrophin-glycoprotein complex
and α-dystrophycan glycosyltransferases for membrane
stability, and the implication of other LGMD proteins in
processes such as regulation of sarcomere structure or
nuclear stability, for the survival of the muscle fibers [9].
No curative treatment is currently available for LGMD,
which pleads for the elucidation of the pathological
mechanisms implicated in the diseases in order to
propose innovative therapeutic approaches.
In this context, we selected a large-scale strategy to
identify novel protein-protein interactions that could
shed light on the biological processes at the origin of
LGMD pathogenesis. We selected 13 LGMD-causing
proteins and related proteins and ran high-throughput
Y2H assays to build a first interactome network that we
further expanded by performing additional secondary
and tertiary Y2H screenings with new bait proteins of
interest identified as preys in the primary screenings.
The resulting LGMD-centered interaction network was
established by combining results of 87 screenings based
on 76 different bait proteins and incorporates 1018
proteins connected by 1492 direct binary interactions.
Using both experimental and bioinformatics tools, we
assessed the overall quality of this Y2H network and
isolated a high-confidence (HC) sub-network of 705
PPIs associating 497 proteins. The Y2H LGMD-centred
network and its HC sub-network were compared to a
literature-based network. Gene Ontology (GO) term
analysis showed that the LGMD-centered interactome
and especially its HC sub-network, is much more specif-
ically enriched in proteins associated with the muscular
tissue and the cytoskeleton than the literature-based
dataset. Among the interesting outcomes of our study are
the strong inter-connectivity of the LGMD proteins which,
in addition to several direct links, present a number of in-
direct associations thanks to sarcomeric proteins, the iden-
tification of candidate genes for orphan neuromuscular
disorders (NMDs) and the discovery of new possible
functions for LGMD proteins. In particular, we suggest the
existence of functional links between LGMD2B/dysferlin
and gene regulation, between LGMD2C/γ-sarcoglycan and
energy control and between LGMD2G/telethonin and
maintenance of genome integrity.
The protein interactions from this publication have been
submitted to the IMEx (http://www.imexconsortium.org/)
consortium through IntAct (pmid 22121220) and assigned
the identifier IM-16425. The entire network can be




Bait design was organized in three successive rounds in
which primary, secondary and tertiary baits were
selected. Structural and functional domain predictions
from TM-HMM [10], SignalP3.0 [11] or PFAM (PFAM
23.0, release 19/08/2008 [12]) were used to exclude
hydrophobic trans-membrane domains, signal peptides
and transcriptional trans-activation domains from bait
constructs. In addition, to favor the identification of
novel protein-protein interactions, we usually selected
regions on the proteins that had not been previously
documented for their functional role. For selection of
secondary and tertiary bait proteins and for design of
their bait sequences, we used additional bibliographic
searches and other criteria computed from our Y2H
results such as the Predicted Biological Score (PBS)
categories and information from Selected Interacting
Domains (SID; see below section “Identification of
interacting fragments and scoring of the interactions”).
Some examples of bait candidates that came to our atten-
tion included targets of choice for therapeutic strategies
such as proteins that participate in signaling pathways,
proteins involved in various forms of myopathies or
proteins expressed in typical muscle cellular compartments
such as the sarcomere or sarcoplasmic reticulum.
Bait cloning and library construction
Bait sequences were PCR-amplified from MRC Gene
Service or Invitrogen plasmids or from a random primed
cDNA library obtained by reverse transcription of a poly
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(A) RNA library isolated from adult (Ambion AM7983)
or 18-19 week-old fetal (Stratagene #778020) human
skeletal muscles. Bait PCR products were cloned in the
pB27 plasmid, a plasmid derived from the original
pBTM116 [13], as a LexA C-terminal fusion [14]. Plasmid
DNA was purified with the QIAprep Spin Miniprep
(QIAGEN), verified by full insert sequencing and
introduced into the L40ΔGal4 (MATa) bait yeast strain
[15]. Alternatively, prey fragments were directly extracted
from the prey plasmid and subsequently cloned in pB27
to use them as secondary or tertiary baits.
The prey library in yeast was constructed from adult
(Ambion AM7983) and fetal (Stratagene #778020)
human skeletal muscle poly(A) RNA. Random-primed
cDNA fragments were prepared from these two RNA
pools and cloned in the pP6 plasmid derived from the
original pACT2 (Clontech) as a C-terminal fusion of the
Gal4 transcription activating domain. Altogether, 90% of
the plasmids contained a cDNA insert with an average
size of 600 bp. After amplification in Escherichia
coli (50-100 million independent clones), the Y187
(MATalpha) yeast strain was transformed with an
equimolar pool of the adult and fetal cDNA libraries.
Ten million independent yeast colonies were then
collected, pooled and stored at -80°C as equivalent ali-
quot fractions of the same prey library. Validation of the
prey library was performed by recapitulating several
published interactions as described in [14]. Bait proteins
belonging to different functional classes were used: a
GTPase (Rac1), a transcription factor (TP53), a splicing
factor (SF1) and a component of a E3-ligase complex
(BTRC).
Screening procedure and identification of prey fragments
Y2H screens were performed using a mating method as
described in [14] at the Hybrigenics facility (Hybrigenics,
Paris). As first step, small-scale screenings were
performed to assess toxicity and auto-activation capacity
of the baits and to adjust selective pressure of the
screens accordingly. In particular, the optimal concentra-
tion of 3-aminotriazol (3-AT) was determined prior to
performing each large-scale screen. Auto-activating
baits able to activate transcription of the reporter
gene by themselves were identified and were not
considered for large-scale screenings. Subsequently,
each bait clone was tested in a full-size screen against
an average of 103 million yeast prey clones, equiva-
lent to ten-fold coverage of the library. All positive
clones were picked and the corresponding prey
fragments were PCR-amplified and sequenced at their
50 and 30 junctions. Sequence contigs were built and
identified by comparison to the NCBI Human RefSeq
database as described in [14].
Identification of interacting fragments and scoring of the
interactions
Following contig assembly of positive clones, the com-
mon sequence shared by the assembled prey fragments
was used to define the SID along each prey protein. Fur-
thermore, for each interaction, a PBS was computed
with E-values ranging from 0 to 1 to establish six dis-
tinct categories: PBS-A to -E (see [14] for details on cal-
culation). The technically most reliable interactions were
associated with the PBS-A, -B or -C categories (with P
values < 1e-10 for PBS-A;< 1 e-5 for PBS-B and < 1e-2.5 for
PBS-C) and are found in two reciprocal and independent
screens (X->Y and Y->X) and/or in interaction cycles (X-Y,
Y-Z and X-Z) and/or in a single screen but with many
overlapping prey fragments. Interactions were assigned to
the PBS-D category when they were supported either by a
single experimental clone from a screen or by several
clones bearing the same start and stop positions, the SID
being identified by a singleton fragment instead of a family
of several overlapping fragments. This PBS-D category
corresponds to a heterogeneous group of interactions that
theoretically could consist of technical false-positive
interactions as well as true-positive interactions hardly
detectable by Y2H systems (due to constraints in tri-
dimensional conformation of bait or prey domains, tox-
icity in yeast, poor mRNA representation of the prey in
the library, . . .). All the PBS-D should therefore be
considered as putative unless validated by a second
technique. The PBS-E category characterizes SID that
have been found as prey in more than ten independ-
ent screens with unrelated bait proteins in all
screenings performed with human libraries at the
Hybrigenics facility. These interactions potentially
represent possible false-positives of the Y2H system
as well as interactions with proteins known to be
highly connected due to their biological function or
with proteins containing a biochemically promiscuous
motif. Finally, interactions with proteins or domains
corresponding to known false positives of the Y2H
system as it is described above were removed from
the data and from our analyses. Examples of yeast
growth assays describing interactions with the differ-
ent PBS categories using the same experimental
procedures can be found in [16-18].
Antibodies
The antibodies used for immunoprecipitation of the baits
are BD Biosciences anti-TCAP (T26820-050), Novocastra
Laboratories Ltd anti-DYSF (NCL-Hamlet) and Santa
Cruz Biotechnology anti-ABI1 (sc-30038), anti-ACTN2
(sc-15335), anti-DES (sc-14026), anti-MYOM1 (sc-30390)
and anti-TCAP (sc-8725).
The antibodies used for prey detection by western blot
are Abcam anti-SNAPIN (ab37496), Abnova anti-ADPGK
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(H00083440-M01), anti-APPL1 (H00026060-A01) and
anti-ENO1 (H00002023-M04), Aviva anti-KBTBD10
(ARP38732_T100) and Santa Cruz Biotechnology anti-
KIF1B (sc28540) and anti-KTN1 (sc33562).
The antibodies used for immunochemistry and
Duolink assays and their corresponding dilutions are:
Abcam anti-CMYA5 (ab75351, 1:50) and anti-OPTN
(ab23666, 1:100), Abgent anti-DGKD (AP8126b, 1:50),
Abnova anti-DNAJB6 (H00010049-M01, 1:100) and
anti-EEF1G (H00001937-M01, 1:50), Novocastra Labora-
tories Ltd anti-DYSF (NCL-Hamlet, 1:20), Proteintech
Group anti-SNAPIN (10055-1 AP, 1:50), Santa Cruz Bio-
technology anti-ACTN2 (sc-15335, 1:100), anti-ALMS1
(sc-54507, 1:50), anti-APPL1 (sc-67402, 1:50), anti-DES
(sc-14026, 1:100), anti-FLNC (sc-48495, 1:100), anti-
KIF1B (sc-28540, 1:50), anti-MYOM1 (sc-30390, 1:100),
anti-MYOM2 (sc-50435, 1:200) and anti-NEB (sc-28286,
1:100) and Sigma anti-NPHP3 (HPA009150, 1:75).
Co-immunoprecipitation
The bait proteins were isolated from R9 cell extracts (a gift
from Dr. Anne Galy, Inserm U790, Evry, France) at
myoblast or myotube stage (7 to 10 days of differentiation)
or from gastrocnemius muscle excised from four week-old
mice and homogenized in 6 ml lysis buffer (Tris 20 mM,
pH 7.5, NaCl 50 mM, EGTA 2 mM, Triton 1%, Protease
Inhibitor Cocktail (Complete mini, Roche), E64 2 μM)
using a FastPrep-24 apparatus (MP Biomedicals). The
mouse samples correspond to a protocol approved by
Genethon’s ethics committee under the number
CE11_014 and performed in accordance with the directive
of 24 November 1986 (86/609/EEC) of the Council of the
European Communities. After centrifugation of the
lysates, 500 μg to 1 mg of proteins in 1 ml were incubated
with 30 μl of protein G–Sepharose beads (Amersham) for
1 h to clear from nonspecific binders. The protein extract
was then subjected to immunoprecipitation by 1 h incuba-
tion at +4°C with 2 to 4 μg of primary antibodies
corresponding to the baits, then 30 μl of protein G
Sepharose beads (Amersham) were added and incubation
was carried out for 2 h or overnight at +4°C.
After centrifugation at 1000 g for 5 min, the
immunocomplex was washed three times with 1 ml of
buffer and resuspended in 15 μl 4x NuPAGE LDS sam-
ple buffer (Invitrogen) and dithiothreitol reducing agent.
Samples were then heated at +70°C for 10 min and
centrifuged briefly. Protein complexes were separated by
electrophoresis on SDS-PAGE NUPAGE 4-12% Bis-Tris
gel (Invitrogen). Transfer of the proteins was performed
on PVDF membrane and verified by staining with
Ponceau red. Immunostainings were performed with
primary antibodies corresponding to prey and IRD-680
or 800 donkey anti-mouse, -rabbit or -goat as secondary
antibodies according to LI-COR’s protocol. Bands were
then visualized with the Odyssey infra-red imaging
system (LI-COR-Biosciences) at 700 nm (red) and
800 nm (green).
Immunohistochemistry
Indirect immunofluorescence microscopy assays were
carried out on transversal cryosections prepared from nor-
mal human paravertebral striated muscles of a 13-year old
female biopsy obtained from the biobank Myobank under
the validation number AC-2008-87 from the French
ministry of research (Institute of Myology, Paris). The
sample was treated anonymously. Frozen slides were air-
dried for 30 min at room temperature, fixed with 4% PAF
for 5 min, washed 3 × 5 min in PBS, incubated in a
blocking buffer (4% BSA, 0.02% Triton) for 30 min,
washed in PBS, then incubated with a biotin blocking
solution (Vector Laboratories, SP-2001) for 15 min and
washed in PBS for 5 min. Slides were stained at room
temperature for 1 h or at +4°C overnight with primary
antibodies diluted in the labeling solution (1% BSA / PBS).
Slides were then incubated with a donkey anti-mouse
-Alexa 488 for dysferlin and a donkey (anti-rabbit or anti-
goat) biotinylated secondary antibody for its partner
(dilution 1:1000) for 45 min, washed 3x 5 min in PBS and
stained with streptavidin coupled to Alexa-594 (Molecular
Probes, dilution 1:500 in PBS) for 30 min. For nucleic acid
staining, slides were then incubated with TOPRO-3
(Molecular Probes, dilution 1:2000) for 5 min, washed 2 x
5 min in PBS and 1x in water for 2 min. Slides were subse-
quently mounted in Fluoromount-G™ (SouthernBiotech,
0100-01). Images were acquired using the 40x or 63x
objective of a Zeiss Axiovert 100 M. LSM.510 Meta laser
scanning confocal microscope and the constructer soft-
ware. Colocalization analyses were performed by statistical
analysis of the correlation between the intensity values of
red and green pixels in a dual- channel image. The JACop
plug-in [19] for ImageJ (Rasband, W.S., ImageJ, U. S.
National Institutes of Health, Bethesda, Maryland, USA,
http://imagej.nih.gov/ij/, 1997-2011 ) was used to calculate
Pearson’s Correlation coefficient. Co-localization was
defined as strong for 0.5<R≤1, medium for 0.25<R≤0.5
and low for R≤0.25.
Proximity ligation assays
The DuolinkW kit (Olink Bioscience) is based on the use
of two unique and bi-functional probes called PLA™,
each probe consisting of a secondary antibody attached
to a unique synthetic oligonucleotide that acts as a re-
porter. After a 10 min fixation with paraformaldehyde
4% and blocking (BSA 5% in PBS) steps, muscle sections
were stained with one or two primary antibodies de-
pending on the experiment (single protein detection or
detection of interacting proteins) over-night at +4°C.
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After washing, the sections were incubated with the sec-
ondary oligonucleotide-linked antibodies (PLA probes)
provided in the kit. The oligonucleotides bound to the
antibodies were hybridized, ligated, amplified, and
detected using a fluorescent probe (Detection Kit 563).
Dots were detected with the Zeiss laser scanning con-
focal microscope and intensity signal counted using
ImageJ software (http://imagej.nih.gov/ij/). A series of
controls were performed for each analysis (bait antibody
only, prey antibody only and negative control for which
the primary antibody is omitted).
For quantification analysis: three images were acquired
under the same conditions (laser power, PMT gain and
pinhole) for each experiment. For each image, five fibers
were randomly selected and used to count all positive
spots within each compartment (total of 15 cells). The
regions of interest (ROI) for membrane and cytoplasm
compartments were separately delimitated manually and
signal quantification was performed on all identified spots
using the ImageJ software. For each compartment, we
considered that the PPI was validated by the assay when
the mean signal ratio between the PLA images of the PPI,
“PPI signal”, and the control images of the prey, “PREY
signal”, was superior to 0.2, indicating that the interaction
with the prey potentially recruited more than 20% of the
interacting partner in the delimited compartment.
Bioinformatics and statistical analyses
IpScan [20] with Interpro 17.0 [21] was used to annotate
the protein sequences. The SID coordinates were
compared with the position of the different Interpro
domains. Cytoscape tools (www.cytoscape.org) were used
to infer connectivity, a parameter that indicates the num-
ber of proteins that directly interacts with a given protein.
Comparison of PPIs identified by our Y2H screenings with
previously published PPIs was performed using the
iRefWeb interface ([22]; http://wodaklab.org/iRefWeb/) by
considering direct interaction found in mammals.
GO mapping and clustering were performed with the
DAVID 6.7 web interface [23,24] using the Functional An-
notation Clustering tool and the GOTERM_FAT annota-
tion categories in order to filter the broadest GO terms.
For the LGMD-centered dataset, a list of official gene
symbols was used to identify the proteins and within each
identified GO cluster, GO terms were analyzed in terms of
hierarchy to identify the most specialized children terms
common to all proteins within the cluster and these terms
were reported as “shared GO” annotations (Additional file
1: Table S1). To analyze whether our datasets were
statistically different from a random dataset, GO
clustering was also performed with a list of Uniprot
accessions for the 19220 human protein-coding genes
(HGNC, www.genenames.org/). The number (Shared-i) of
human proteins with which a given bait protein (Bait-I)
shared a GO cluster was calculated for all three GO
classes (BP, MF and CC) and all baits and the number of
protein pairs not sharing a GO cluster was deduced
(NonShared-i = 19220 - Pi). The overall frequency of
expected shared and non shared protein pairs was
calculated as the ratio between the sum of Shared-i and
the sum of all pairs (76 × 19220), and the sum of
NonShared-i and the sum of all pairs, respectively. A Chi-
2 test (P<0.05) was used to compare expected values with
observed values from the LGMD-centred dataset or the
subset consisting of all PBS-A to -C categories.
GO enrichment analyses were performed using the
DAVID Functional Annotation tool with Uniprot acces-
sion numbers as identifiers, the Homo sapiens back-
ground and the GOTERM_FAT annotation categories.
Enrichment at 1% significance level was defined with a
modified Fisher exact P value (the “EASE” score) as
recommended by the DAVID interface.
Statistical analysis of obtained proportions for the other
analyses was done using the Fisher test function in R.
Results
Bait design and screening procedure
The procedure for choosing the bait protein sequences
to be used as baits for our Y2H screenings lied in three
successive steps in which primary, secondary and tertiary
baits were selected to perform three rounds of Y2H
screenings. First, we selected nine proteins involved in
recessive LGMD forms and four proteins that were ei-
ther known as LGMD-binding proteins or described as
having a role in muscular atrophic processes (Table 1).
Design of the baits excluded hydrophobic trans-
membrane domains, signal peptides and transcriptional
trans-activation domains to ensure the best Y2H
screening conditions. We chose either full-length coding
sequences or specific domains as bait, especially, for
large proteins such as titin (TTN) and dysferlin (DYSF).
Overall, we selected 20 primary bait domains.
For each bait domain, we first assessed its toxicity and
auto-activation capacity by a small-scale Y2H screen and
then performed a large-scale Y2H assay by screening a
high-complexity cDNA prey library obtained by random
priming of poly(A)+ RNA from adult and fetal human
skeletal muscles that we constructed for this purpose.
The bait interaction was tested against an average of 103
million prey clones to insure a ten-fold coverage of the
prey library. Positive prey clones were sequenced and
compared to the NCBI human RefSeq database for prey
identification. Contig assembly of positive clones was
performed to isolate the minimum interacting domain(s)
on each prey sequence [Selected Interacting Domains
(SID)]. We used clone coverage and local topology infor-
mation to compute a confidence score [Predicted
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Biological Score (PBS)] and classify each PPI into five
categories: PBS-A, -B or -C for the most reliable
interactions, PBS-D for putative interactions involving a
single bait clone and PBS-E for interactions involving
highly connected proteins.
We then examined the interaction networks resulting
from the first screenings according to the PBS categories
and literature data and conducted selection of secondary
and tertiary baits. First, we isolated 54 prey proteins of
interest to design 57 new bait domains for a second round
of screenings and then, we used the resulting Y2H
network to select 10 additional proteins corresponding to
11 baits for a third and last round of screening. Two of
the chosen baits showed autoactivation capacities
(CMYA5Q3501-K4069 and RCOR3M1-L296 fragments) and
were therefore discarded. Overall, we successfully carried
out 87 large-scale Y2H screenings using 76 different bait
proteins. The comprehensive set of baits is listed in
Additional file 2: Table S2.
General properties of the Y2H interaction map
The 87 screens led to the identification of 1625 SIDs.
On average, each Y2H assay yielded 18.7 SIDs with a
range of 1 to 107. This corresponds to a mean of 19.7
PPIs per bait protein with 53 pairs of connected proteins
showing two or more SIDs on the prey protein (Table 2).
Performing secondary and tertiary screenings theoretic-
ally allowed us to identify reciprocal hits between the
secondary/tertiary bait protein and the protein it was
originally found to interact with. Practically, reciprocal
screenings were not symmetrical because the prey and
bait domains were expressed as fusion with a DNA-
binding or GAL4-activating domain, respectively and
because domains first identified as prey, and then chosen
as bait, were rarely identical for practical cloning
reasons. Nevertheless, we were able to reciprocally de-
tect nine interactions (Additional file 1: Table S1) that
were automatically grouped into the PBS-A category.
Results from all individual Y2H screenings were
assembled in a single network of 1492 PPIs connecting
1018 proteins (LGMD-centered network, Figure 1).
Topological analysis of this network using the Cytoscape
platform (www.cytoscape.org) revealed an average con-
nectivity of 2.88 partners per connected protein. The
mean shortest path length between any of two proteins
was calculated as 3.75. The set of interactions presenting
the highest level of confidence consists in the PPIs
ranked into the PBS-A, -B or -C categories and
Table 1 A/Description of primary baits





calpain 3 CAPN3 (LGMD2A) T417-S643 C2-like domain + exons15-16
M1-A822 full length protein with the C129S mutation in the autocatalytic
site
dysferlin DYSF (LGMD2B) L2-I485 N-terminal DYSF regions containing the first three C2 domains
Q851-D1200 central DYSF domain
I1145-L2026 C-terminal DYSF domain containing the last four C2 domains and
excluding the transmembrane span
γ- sarcoglycan SGCG (LGMD2C) M1-L36 cytoplasmic domain
α-sarcoglycan SGCA (LGMD2D) M313-H388 cytoplasmic domain
β-sarcoglycan SGCB (LGMD2E) E10-A65 cytoplasmic domain
δ-sarcoglycan SGCD (LGMD2F) E1-Y36 cytoplasmic domain
titin-cap (telethonin) TCAP (LGMD2G) M1-G167 full length protein
tripartite motif-containing 32 TRIM32 (LGMD2H) L66-P654 full length protein minus the RING domain
titin TTN (LGMD2J) V97-K469 exons 4-8 from the Z-Disc region
I741-G948 exons 14-17 from the Z-Disc region
R2120-L2564 exons 28-33 from the Z-Disc region
A8831-E9158 exons 108-114 from the N2A-PEVK region
T32840-I33423 exons 358-363 from the Mline region
ankyrin repeat domain 1 ANKRD1 M1-F319 full length protein
ezrin EZR M1-S536 full length protein minus the actin-binding C-terminal domain
F-box protein 32 (MAFbx) FBXO32 M1-F356 full length protein
tripartite motif-containing 63 (MuRF1) TRIM63 M1-Q354 full length protein
* amino acid coordinates refer to the translated products of the nucleotide sequences indicated in Additional file 2: Table S2.
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comprises 32.9% of all PPIs, a figure similar to the one
found by [14]. This set defined the most probable true-
positive interactions and comprised 491 PPIs consisting
of 376 interacting proteins. Among the other remaining
interactions, 53.6% and 13.5% were classified in the PBS-
D and -E categories, respectively. The high level of PBS-
D interactions reflects the high complexity of the
screened library and the fact that it is screened to satur-
ation but should be considered as putative. General
properties of the LGMD-centered interaction map are
summarized in Table 2 and the complete list of PPIs
along with their PBS category is available in Additional
file 1: Table S1.
Examination of interaction domains
Contrasting with other Y2H approaches in which bait
proteins are tested against full-length prey libraries [1,2],
our approach was domain-oriented since the prey library
was generated as random-primed cDNA with an average
fragment size of 800-1000 bp and since some of the baits
consisted of selected domains. For each prey protein
involved in a PPI ranked in the PBS-A, -B or –C
categories, we analysed its SID(s) and compared their
coordinates with predicted InterPro domains to detect
SIDs that were included in or included a documented
domain. In total, 601 SIDs were computed and showed
an average size of 176 aa (Additional file 3: Table S3).
This analysis resulted in the identification of 311 distinct
SIDs that could be unambiguously associated with one
or more InterPro domains either because they were fully
included within one such domain (82 SIDs) or because
they fully included one or several of them (248 SIDs).
The most frequent InterPro domains found within SIDs
(in more than 4% of the SIDs; Table 3) were
Immunoglobulin-like domains (IPR003599; IPR003598
and IPR007110), Zinc Finger C2H2 (IPR007087),
Fibronectin type III domain (IPR003961), Ankyrin repeat
(IPR002110) and Nebulin motif (IPR000900). Finally, we
compared the occurrence of InterPro domains fully
included within the set of analyzed SIDs with their
occurrence in the full human proteome according to
[25]. Interestingly, three among the five top-ranking
domains in Human were also present with a high fre-
quency in the analyzed dataset although with different
ranks and percentages (Table 3). The other two most fre-
quent domains in our subset (Ankyrin repeat and Nebulin
motif) were largely over-represented (p-value = 7.62e-16
and <2.81e-20, respectively) compared to the global
human proteome whereas the three and four top-ranking
domains in Human (EGF/laminin and P-loop nucleotide
triphosphate hydrolase) were scarce in the analyzed SIDs.
Quality assessment of the Y2H network
For all large-scale studies aimed at experimentally identi-
fying molecular interactions, the technical false positive
rate is of special concern. We addressed this problem
with the assignment of a PBS category. Furthermore, lit-
erature mining, cross-validation assays, and functional
correlations were used to further estimate the overall so-
lidity of the network.
Comparison with known interactions data
We first compared our LGMD-centered Y2H dataset
with literature-curated interactions between the
corresponding mammalian proteins that are referenced
in the molecular interaction database iRefWeb (http://
wodaklab.org/iRefWeb/ [22]). This web interface reports
data on PPIs consolidated from major public databases
such as IntAct, BIND or HPRD. Among our PPIs, 72
were already reported, representing 4.8% of our map
(Additional file 1: Table S1), a figure slightly above
others found in large-scale Y2H studies aimed at explor-
ing the human interactome (3.4% [2] and 3.8% [6]). We
observed a strong enrichment for literature-based
interactions within the PBS-A category for which 18% of
PPI (43) correspond to previously known interactions
(p-value = 1.54e-18), thus confirming the correlation be-
tween the PBS and the biological significance of the
interaction.
Experimental cross-validations
To provide more evidence that the identified physical
interactions are genuine, we applied different experimental




Total number of bait domains/
proteins
87 / 76
Average number of tested diploids 103 106 per
screen
20 106 - 203
106











Average number of SIDs per
bait domain
18.7 1-107




Total number/average size of
identified SIDs
1625 /231aa
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techniques that enable detection and visualization of
protein interaction. We first tested a subset of PPIs for the
baits: abl-interactor 1 (ABI1), DYSF, enolase 1 (ENO1),
SNAP-associated protein (SNAPIN) and telethonin
(TCAP), using co-immunoprecipitation in murine R9 myo-
genic cells at myoblast or myotube stages or in gastrocne-
mius mouse muscle. A large proportion of the 42
interactions tested were technically inconclusive due in part
to the quality of the available antibodies or stickiness of
both proteins. Among the 14 technically conclusive, 9
(64%) were confirmed as positive by the co-immuno-
precipitation assays (1 PPI for ABI1, 5 for DYSF, 1 for
SNAPIN and 2 for TCAP; Figure 2 and Additional file 1:
Table S1). Several interesting outcomes emerge from these
validations that reinforce and extend the knowledge we
have on LGMD proteins or open new directions for spe-
cific areas of research. For example, the interaction be-
tween DYSF, the LGMD2B protein, and SNAPIN, a
component of the SNARE complex that is required for
vesicle fusion [26] is appealing with regard to the role of
Figure 1 The LGMD-centered network. A total of 87 Y2H screens was performed starting from the LGMD proteins. Results from all individual
Y2H screenings were assembled in a single network of 1492 PPIs connecting 1018 proteins. Primary baits are depicted as yellow rectangles.
Secondary and tertiary baits are depicted as grey octagons. Preys are depicted as white circles. Interactions between pairs of proteins (nodes) are
depicted by edges with colors according to the PBS category (PBS-A: red, PBS-B: dark blue, PBS-C: green, PBS-D: light blue, PBS-E: light pink). To
visualize details on the image, readers are invited to zoom in.
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DYSF in membrane repair [27]. The positive interaction
between kinectin (KTN1), a kinesin anchoring protein
that modulates the endoplasmic reticulum interaction
with the microtubule and that is known to interact with
Rho GTPases [28], and ABI1, an adaptor protein involved
in the transduction of signals from Ras to Rac and the
regulation of actin polymerization [29], suggests a role for
this interaction in the regulation of the muscle cytoskeletal
remodeling.
We then investigated intracellular co-localization on
normal human muscle sections of one particular bait,
DYSF, with its Y2H partners for which quality antibody
was available for immuno-fluorescence assays. Among
the 14 PPIs investigated, five showed no apparent co-
localization while the others demonstrated different
degrees of co-localization at the sarcolemma and/or in
the cytoplasm (Figure 3). Analysis of Pearson’s coeffi-
cient showed that DYSF labeling presented a strong cor-
relation with the cardiomyopathy-associated protein 5
(CMYA5, 0.567), DES (0.656), filamin-C (FLNC, 0.521),
kinesin family member 1B (KIF1B, 0.566) and optineurin
(OPTN, 0.733), a medium correlation with Alstrom syn-
drome protein 1 (ALMS1, 0.402), diacylglycerol kinase
delta (DGKD, 0.309), and nebulin (NEB, 0.332) and a
low correlation with SNAPIN (0.12).
We also visualized the sub-cellular localization of the
interactions using a Duolink proximity ligation assay
(PLA) for 44 PPIs. The Duolink technology is a combin-
ation of immunohistochemistry and rolling circle ampli-
fication and is based on the use of bifunctional probes
consisting of a secondary antibody attached to a syn-
thetic oligonucleotide. It generates a quantifiable signal
indicative of close proximity (<40 nm) between two
antigens. For our purpose, primary antibodies against
five different baits [DYSF, OPTN, γ-sarcoglycan (SGCG),
adaptor protein containing PH domain, PTB domain
and leucine zipper motif 1 (APPL1) and myomesin2
(MYOM2)] and some of their partners identified in our
Y2H screenings (18 interacting partners for DYSF, 10 for
OPTN, 3 for SGCG, 3 for APPL1 and 5 for MYOM2)





Figure 2 Immunoprecipitation analysis of a subset of interactions. A subset of interactions from the baits: abl-interactor 1 (ABI1), DYSF,
SNAP-associated protein (SNAPIN) and telethonin (TCAP) was assessed using co-immunoprecipitation using myogenic cells or in gastrocnemius
mouse muscle. Immunoblotting was performed with anti-prey antibody. Left lanes= input sample. Middle lanes: Protein lysates co-
immunoprecipitated with anti-bait antibody. Right lanes= negative control where the primary antibody was omitted. One PPI for ABI1, 5 for DYSF,
1 for SNAPIN and 2 for TCAP were confirmed as positive by the co-immunoprecipitation assays.
Table 3 Most frequent domains in the LGMD-centered dataset and representativeness in the human proteome
Domains
% in the total of SID % in the human proteome
(according to Müller et al., Genome Res 2002)
Immunoglobulin (IPR003599; IPR003598; IPR007110) 22.5% (n=141) 4.2% (n=1214; r=2)
Zinc finger, C2H2-type (IPR007087) 12.8% (n=80) 17.6% (n=5092; r=1)
Fibronectin type III (IPR003961) 9.63% (n=60) 2.9% (n=842; r=5)
Ankyrin repeat (IPR002110) 5.3% (n=33) 0.9% (n=278; r=14)
Nebulin 35 residue motif (IPR000900) 4.5% (n=28) n.i.
(n.i.= not indicated; n= number of occurrences; r= rank in the human proteome).
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were used to obtain a PLA “PPI signal”. In a separate ex-
periment, only the primary antibody of the prey was
used to generate the “Prey signal”. In this way, the cellu-
lar site(s) where the binary interactions were occurring
could be visualized. Among the 44 tested interactions,
34 showed a “PPI signal” with various proportions be-
tween membrane and cytoplasm. An image analysis was
performed to calculate the ratio of the “PPI signal”
compared to the “Prey signal” separately at the mem-
brane or cytoplasm locations (Figure 4A). Two examples
of DYSF interactions are depicted in Figure 4B. The sin-
gle protein detection of DYSF revealed as expected the
presence of the protein at the membrane and at the T-
tubule network within the cell (Figure 4B). The APPL1
protein seems almost entirely engaged in the interaction
with DYSF both at the membrane and cytoplasm
locations. In contrast, DES/DYSF association was
visualized only at membrane level.
In total and among the 54 PPIs investigated using
these three different techniques, 40 interactions were
considered as relevant by at least one technique (74%)
with 20 of them from the PBS-A, -B, or -C categories
and the others from the PBS-D category. The 26%
remaining interactions identified by our Y2H screens
that could not be experimentally cross-validated in our
hands consist in 3, 3, 2 and 5 interactions classified in
the PBS-A to –D categories, respectively.
Examination of GO annotations
We performed computational analyses using the Data-
base for Annotation, Visualization, and Integrated Dis-
covery (DAVID) web-resource (http://david.abcc.ncifcrf.
gov/) to detect pairs of interacting proteins known to
participate in similar biological processes (BP), to be part
of the same cell components (CC) or to perform similar
molecular functions (MF). In the LGMD-centered
network, 84, 72 and 82% of proteins were annotated for
the BP, CC and MF GO categories, respectively. Among
the annotated proteins, we identified 449 pairs of
proteins (30%) that share a GO annotation, including
168 pairs within the PBS-A, -B, or -C categories (34%;
Additional file 1: Table S1). More precisely, among PPIs
from the PBS-A, -B and -C categories, a significantly
higher number of PPIs with shared BP or CC GO
Figure 3 Co-localization analyses of dysferlin and its partners.
Double immunostaining for DYSF (Alexa488, green) and its Y2H
partners (Alexa594, red) in cross human muscle cryosections by
alphabetic order. The images were taken with a 40x objective for
DES, FLNC, and NEB and a 63x for OPTN, KIF1B, DGKD, SNAPIN, and
CMYA5. Scale bars = 20 μm. The Pearson’s coefficient is indicated
under the merge image for each PPI. As expected, DYSF showed a
membrane-associated pattern and a reticular cytoplasmic pattern
corresponding to T-tubules on transversal section. Depending on
the tested protein, the partner pattern is variable.
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annotations compared to the Human proteome were
detected (Chi-2 test, P<0.05, Figure 5), confirming again
the correlation between the PBS and the biological
significance of the interaction.
The NMD proteins in the LGMD-centered network
We examined our LGMD-centered interactome map to
pinpoint interactions involving proteins identified as the
genetic cause of one or more hereditary NMDs by
searching the OMIM database. We identified 199
proteins of the network that are associated with human
monogenic diseases including 77 proteins whose defects
have been described as the genetic cause of one or more
hereditary NMD (Additional file 4: Table S4) . Among
this last group, 43 proteins correspond to myopathies in-
cluding the recently described DNAJB6 [30], 20 to
Figure 4 Proximity ligation assays of a subset of interactions. A/ Graphs showing the ratio of the signal for the PPI divided by the signal for
the prey protein alone with respect to the ROI corresponding to membrane (light grey) or cytoplasm (dark grey) for the bait proteins DYSF,
APPL1, MYOM2, OPTN and SGCG. Prey proteins are named with their gene symbol. The line corresponding to 20% is indicated for each graph.
For technical reasons, in the case of DYSF/SGCG and MYOM2/TTN interactions, the PPI/prey ratio is calculated as the ratio of SGCG and TTN
molecules with respect to DYSF and MYOM2 although DYSF and MYOM2 were found as preys of SGCG and TTN baits. For MYOM2 and OPTN,
two TTN antibodies were tested with epitopes at the Z-disc and N2A regions, respectively. Among the 44 tested interactions, 34 showed a “PPI
signal” with various proportions between membrane and cytoplasm. B/ Representative confocal images of PLA results. Duolink amplifications are
visualized by fluorescence (white dots). Upper panels: PLA+/- labeling of single proteins. Left panel = negative control consisting of DYSF with
probes corresponding to the PPI for evaluation of background staining. Middle panel: the DYSF-APPL1 interaction signal showed a strong
labeling both at the membrane and the cytoplasm. Right panel: the DYSF-DES labeling showed that the signal is mainly located at the
membrane. Scale bars= 20 μm.
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cardiomyopathies, 17 to neuropathies, 8 to metabolic
muscle diseases, 3 to excitation abnormalities and 8 to
unclassified NMD. From these 199 proteins, it was pos-
sible to construct a protein interaction network includ-
ing 88 proteins in 113 interactions (Additional file 5:
Figure S1). No specific repartition of NMD and non-
NMD proteins was noticed.
We then examined the sub-network consisting of all the
LGMD and other known NMD-causing proteins, and
their interacting partners. This sub-network contains 56
proteins whose defects have been described as the genetic
cause of one or more hereditary NMD. Aside from the
nine LGMD proteins used as baits in our screenings, this
network contains three additional LGMD proteins, plectin
(LGMD2M), myotillin (LGMD1A) and lamin A/C
(LGMD1B). Thirty-five connections of LGMD-proteins
with other NMD-causing proteins were identified with 28
novel and direct interactions. In particular, this analysis
revealed three novel direct interactions linking TTN,
DYSF and SGCG (Figure 6A). We examined the type of
diseases the non-LGMD proteins are responsible for and
found that proteins involved in congenital and metabolic
myopathies as well as other neuromuscular disorders were
significantly over-represented (p-value= 1.04e-05, 0.025
and 0.040, respectively). It should be noted that the
proteins involved in the metabolic myopathies glycogen
storage disease type 13 (GSD13) and glycogen storage dis-
ease type 5 (GSD5), that are β-enolase (ENO3) and the
muscle form of glycogen phosphorylase (PYGM), respect-
ively, present a high number of physical interactions with
the LGMD proteins group. Interestingly, we observed the
existence of a dense network around the group of LGMD-
causing proteins with many of them linked by paths of
three nodes or shorter (Figure 6B). It can be noted that
among the hub proteins in this network are proteins
located at three important positions of the sarcomere:
actinin α2 (ACTN2) for the Z-disc, myosin-binding
protein C, slow-type (MYBPC1) and MYBPC2 for the
N2A-line and MYOM2 for the M-line.
Considering that the LGMD-centered interactome is
strongly enriched in known NMD-causing proteins, we
expect that some yet-uncharacterized NMD-causing
proteins are part of our interaction network. We
examined in more detail the candidate genes for the or-
phan LGMDs. In addition to the causative genes for 4
dominant and 17 recessive LGMD forms that are known
so far, genetic linkage analyses have been used to map
loci for three new LGMDs. These orphan LGMD loci
contain between 13 and 45 genes, with a total of 2 genes
encoding proteins of the LGMD-centered interactome.
Consequently, FLNC and protein transport protein
Sec31A (SEC31A) were isolated as unique candidates for
LGMD1F and LGMD1G, respectively. No gene from the
LGMD-centered interactome was found within the
LGMD1E locus.
Properties of the LGMD-centered network and biological
functions of the proteins
To investigate which biological functions are associated
with the LGMD-centered network, we performed a GO
term enrichment analysis. In this analysis, we compared
the LGMD dataset to a high-confidence (HC) network
encompassing the most meaningful PPIs as defined with
combined results from the experimental and computa-
tional analyses described above and a literature-based
network.
The HC dataset was built by extracting from the
LGMD-centered map the 491 PPIs classified in the PBS-
A, -B, or -C categories plus PPIs from the PBS-D and -E
categories for which we obtained additional evidence of
the interaction. First, we added the 22 of our Y2H
interactions from the PBS-D or -E categories that have
been described in other studies (Additional file 1: Table
S1). Second, PPIs from the PBS-D or -E categories were
Figure 5 Fraction of proteins pairs sharing a GO annotation cluster. Each bar represents the fraction of proteins pairs that share a cluster
within each of the three GO categories (biological processes, cell components or molecular functions; percentage indicated). Asterisks above the
bars indicate an observed value statistically different from the one expected in the Human proteome dataset (Chi-2 test, P<0.05).
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added to the HC dataset if experimental results from co-
immunoprecipitation, immunofluorescence or PLA as
described above confirmed the Y2H interaction. In total,
20 experimentally cross-validated interactions from the
PBS-D category were included in the HC dataset. Third,
were also included in the HC network, 107 pairs of
interacting proteins from the PBS-D or -E categories that
either share a BP GO annotation or share a CC and a MF
GO annotation. Finally, since our dataset unraveled a high
average level of relationship between NMD proteins, 65
A
B
Figure 6 The network linking the LGMD proteins. A/ Interactions between pairs of LGMD proteins. Interactions are depicted by black lines if
previously reported and in red if detected in our work for the first time. B/ Subnetwork presenting links of three nodes or shorter with LGMD
proteins. LGMD2 proteins and their preys are depicted as yellow and grey nodes, respectively. Only preys that show at least two interactions with
LGMD proteins are presented. The figure indicates the existence of a dense network around the group of LGMD-causing proteins.
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PPIs in the PBS-D and -E categories and involving a
NMD prey protein were added to the HC network. The
resulting HC dataset consists of 497 proteins and 705 PPIs
(Additional file 1: Table S1) and includes 174 and 40 PPIs
from the PBS-D and -E categories, respectively.
The literature-based dataset was constructed by combin-
ing all direct protein-protein interactions reported in the lit-
erature for proteins of the HC dataset or LGMD-causing
proteins that were not included in our initial set of baits. It
is interesting to note that only two interactions for the five
LGMD glycosyltransferases have been identified in previous
reports [between Fukutin and protein O-linked-mannose
beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1)
and between protein O-mannosyl-transferase 1 (POMT1)
and 2 (POMT2)]. Since the glycosyltransferases are all
described or predicted to be single or multipass membrane
proteins, the rarity of PPI and their absence in our LGMD-
centered network are possibly explained, since identifica-
tion of interactions in the vicinity of membranes has proven
to be difficult with the Y2H method. We searched for previ-
ously published experimental binary and direct interactions
using the iRefWeb interface and identified 2675 direct bin-
ary interactions (Additional file 6: Table S5). This literature-
based network consists of 2239 proteins and 3304 PPIs.
Characteristics of the three networks were analyzed
(Table 4) [31]) and showed a connectivity of 0.022, 0.024
and 0.041 for the original and HC LGMD-centered
networks and the literature-based network, with the
proteins being associated with 19.7, 9.7 and 25.4 PPIs on
average, respectively. Network heterogeneity, a param-
eter that reflects the tendency of a network to contain
hub nodes was 2.895, 1.964 and 3.833 for the original
and HC LGMD-centered networks and the literature-
based network, respectively.
Using the DAVID web-resource and an appropriate
level of abstraction of the annotations, we performed a
GO term enrichment analysis of the three datasets in
order to check if they presented any specificity in terms
of biological process, cellular localization or molecular
function of their proteins as compared to the human
proteome (Figure 7). Not unexpectedly, they show an
over-representation of proteins involved in muscle biol-
ogy, even quite exclusively for both the original and HC
LGMD-centered networks that share very similar
profiles (Figure 7). The biological processes with most
striking enrichments in all datasets are muscle contrac-
tion, cytoskeleton organization and muscle organ devel-
opment. The cellular components with the highest
representation include contractile fibers and cytoskel-
eton. The enriched molecular functions are cytoskeletal
protein binding and structural constituents of muscle
protein. In addition to these terms, the literature-based
network shows additional terms with a significant en-
richment of proteins involved in cell cycle and death,
localized in the cytosol and the nucleus and with
broader molecular functions (binding of enzyme, tran-
scription factor or ATP and protein kinase).
A table explaining the component of all the supplements
is added as Table 5.
Discussion
Our Y2H experimental strategy was a large-scale protein
domain-based approach using a methodology that has
been previously successfully implemented [14]. As
compared to approaches where baits are screened
against full-length prey proteins, a domain-based ap-
proach offers several advantages including the possibility
of narrowing down interaction domains and of reducing
the false negative discovery rate by allowing a more effi-
cient folding of domains [32]. A similar approach used
in the field of ataxia identified interactions that were
missed in a previous full-length protein-based approach
[33]. Interestingly, this domain-based approach enabled
us to analyze possible bias in interacting domains. We
found that the three most frequent domains present in
the SIDs (Immunoglobulin-like, Zinc Finger and
Fibronectin domains) are also amongst the most fre-
quent ones in the human proteome, emphasizing how
important biomolecular interactions are for cellular
processes. Two other domains (Ankyrin repeat and
Nebulin motif ) were frequently reported in the SIDs
whereas they are rare in the human proteome. These
domains were established as useful for meeting the
demands of skeletal muscle physiology and constraints
[34,35]. Auto-binding capacities of ankyrin repeats lead
to mechanical-resistant dimers and nebulin-like domains
play a role in the regulation of muscle contraction, espe-
cially through their interaction with actin and the thin
filament. On the other hand, two domains frequently
found in the human proteome (EGF-like and P-loop
domains) are underrepresented in our set of interacting
domains. This observation could be explained either by
the function of the domain; the P-loop motif is known
to be involved in hydrolysis of ATP and GTP but not in
protein-protein interaction; or by a technical bias as in
the case of the EGF-like domain which principally serves
as an interacting domain within extracellular protein
modules. The underrepresentation of this last domain is
Table 4 Comparison of the three networks
Original HC Literature-
based
Number of proteins 1018 497 2239
Number of PPIs 1492 705 3304
Average number of partners per bait
protein
19.7 9.7 25.4
Mean connectivity 0.024 0.022 0.041
HC: high-confidence; PPI: protein-protein interaction.
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probably related to the fact that the LGMD proteins are
intracellular proteins with the exception of sarcoglycans
but for which the intracellular domain was selected for
the Y2H screening.
The utility of any network obviously depends on the
quality of the data. Our approach resides in the exploit-
ation of random-primed cDNA libraries constructed from
human skeletal muscle poly(A) RNA. It minimizes the risk
of detecting interactions between proteins that would not
be co-expressed in the muscle tissue and therefore
should reduce the number of biological false positives. In
addition, assignment of a PBS score using a statistical
method allowed us to classify each PPI identified in our
Y2H assays into five predictive categories, ranging from
the most reliable interactions to possible technical false
positives. The PBS score was previously demonstrated to
successfully predict the reliability of a PPI on a subset of
Y2H interactions where the authors experimentally
Figure 7 GO enrichment analysis of the three datasets compared to the human proteome. A GO term enrichment analysis of the three
datasets (LGMD-centred, HC and literature-enriched datasets) was performed using the DAVID web-resource and an appropriate level of
abstraction of the annotations, The bar charts depict enriched GO terms of the three datasets compared to the human proteome in the three
branches of the GO structure as a function of the EASE score.
Blandin et al. Skeletal Muscle 2013, 3:3 Page 15 of 19
http://www.skeletalmusclejournal.com/content/3/1/3
confirmed 79% of all PPIs from the PBS-A, -B or -C
categories by pull-down or co-immunoprecipitation assays
[14]. The PBS takes into account both local parameters,
such as the number of identical or independent fragments
found for each partner and global information derived
from the entire network such as reciprocal interactions,
highly connected domains etc. . . Our screens identified a
high percentage of the PBS-D interactions (53.6%) which
reflects the high complexity of the constructed muscle li-
brary and the fact that this library is screened to
saturation. As a consequence, the rate of false negatives
should be extremely low, as even rare transcripts in the li-
brary, or weak or transient interactions, could be detected.
In line with the notion that PBS-D interactions might
be more difficult to detect, a higher proportion of
interactions from the ABC categories than from the D cat-
egory can be confirmed by other methods, such as co-
immunoprecipitation or pull-down [14]. However, they
could also represent false positive interactions and should
be considered with caution. Finally, over 210 publications
(full list available http://www.hybrigenics-services.com/
publications/index/list). Of note, 27% of the publications
reporting the functional validation of protein interactions
identified using the same Y2H methodology correspond
to the validation of a D interaction. This indicates that a
significant proportion of such low confidence Y2H
interactions are functionally relevant.
In the present study, we further confirmed the relevance
of the PBS score with computational and experimental evi-
dence. First, nearly a fifth of the PBS-A PPIs were found to
have been previously reported whereas this figure falls to
less than 5% when considering the whole interactome. Sec-
ond, co-immunoprecipitation assays confirmed as positive
11 out of 16 technically conclusive tests (69%) and PLA
validated 34 of the 44 tested interactions (77%). Although
there is often limited overlap between studies [2,36], prob-
ably in part because of the spatial and temporal aspects
of the proteome interaction, we compared our results
obtained for DYSF with a recent study that analyzed the
composition of DYSF complexes in cultured myoblasts,
myotubes and skeletal muscle tissues by mass spectrometry
and bioinformatics methods [37]. Interestingly, 19 (14%) of
the 136 DYSF interactions identified by our large-scale Y2H
screening were also found in the de Moree’s study, a ratio
that is a little higher than what is usually observed [3]. In
contrast, only 3 interactions (TTN, ACTN2 and DES) were
found in a study based on Fisher’ method [38] and none in
another in silico study [39].
Remarkably, results of our Y2H screens led to a single
connected network where the different LGMD proteins are
highly connected. The strong inter-connectivity between
LGMD proteins is illustrated by a high number of direct
interactions. This was quite surprising since, even if the dif-
ferent LGMD forms share seemingly close clinical
phenotypes, the LGMD-causing proteins have been
described to have quite diverse locations and biological
functions. In addition to identifying a remarkable number
of direct interactions between LGMD proteins, mining the
data revealed that LGMD proteins belong to a highly
connected network of interacting proteins with, in particu-
lar, the sarcomeric proteins ACTN2, MYBPC1, MYOM1
and MYOM2 identified as hub proteins sharing the highest
number of links with the LGMD proteins. Interestingly,
these proteins are structural proteins located at key places
on the sarcomere, the Z-disc, the N2A-line and the M-
band. GO analyses further support the crucial place of the
cytoskeleton in the connections between LGMD proteins.
Taken together, these data suggest that common molecular
mechanisms underlie the pathogenesis of these diseases
and highlight the sarcomere as an important platform for
skeletal muscle homeostasis and myofiber survival.
We expect that our interaction map can serve as a new
tool to accelerate discovery of the causative mutated genes
for orphan LGMDs or for other orphan NMDs already or
not yet described as well as to identify modifier genes.
Examination of the chromosomal location of all the genes
coding for the proteins that are part of our original
interactome map revealed putative candidates for orphan
NMDs of which FLN and, SEC31A appeared to be of par-
ticular interest for LGMD1F and LGMD1G, respectively.
Defects in the FLNC gene coding for an actin-binding
protein, are already known to cause myofibrillar myop-
athies [40] but the gene was supposedly excluded as being
involved in the pathogenesis of LGMD1F [41]. Neverthe-
less, non-coding sequences were not fully investigated for
pathogenic mutations and, as mentioned by the authors,
the gene remains a possible candidate. The SEC31A gene
coding for a component of a protein complex responsible
for vesicle budding from the endoplasmic reticulum
[42], has not been associated with any disease. It is an
interesting candidate since LGMD1G is associated with
progressive limitation of fingers and toes flexion [43] and
Table 5 Additional file contents
Additional file Contents
Additional file 1: Table S1 gives a comprehensive list of all the
identified PPI
Additional file 2: Table S2 gives comprehensive information
about the baits and Y2H screenings
Additional file 3: Table S3 gives the list of all the SIDs
Additional file 4: Table S4 presents the Human diseases associated
with the proteins of the network
Additional file 5: Figure S1 presents a sub-network composed of
the disease-related proteins only
Additional file 6: Table S5 gives the list of the PPIs for the
literature-based network
PPI: protein-protein interaction; SID: selected interacting domain; Y2H: yeast-
two hybrid.
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SEC31A has been linked to collagen secretion [44]. In
addition to the LGMD proteins, there is a high proportion
of proteins involved in congenital and metabolic myop-
athies in our network, therefore it is very likely that causa-
tive genes for genetically uncharacterized forms of these
two groups of diseases lie within our interactome.
An interesting outcome of our study is to provide new
PPIs that further support and extend previous findings
and pinpoint new pathways of interest that could be
affected in LGMD. For example, two novel interactions
of calpain 3 (CAPN3) with, ring finger protein 167
(RNF167), an E3 ubiquitin-protein ligase, and the prote-
asome maturation factor (POMP) are of particular inter-
est considering a previous report indicating that CAPN3
acts upstream of the ubiquitin-proteasome system [45].
For DYSF, a number of new interacting partners can be
categorized in three different cellular processes: endo-
cytosis, microtubule-related transport and regulation of
gene expression. The first two pathways fit well with
previous knowledge about DYSF functions but, interest-
ingly, the third pathway indicates a new possible role for
this protein. Another interesting finding in view of the
fact that the pathogenesis of SGCG deficiency does not
seem strictly related to membrane stability [46,47], is the
possible relationship of this protein with energy control-
ling pathways since interaction with proteins involved
in glycolysis or glycogenolysis (enolases 1 and 3 and
PYGM) or in the TCA cycle (SUCLG2, ACO1) was iden-
tified. Finally, several partners detected for TCAP sug-
gest that it may play a role in the maintenance of
genome integrity, in accordance to the recent report
showing a relationship between TCAP and p53 turn-
over [48]. These elements provide new avenues to ex-
plore for a better understanding of the pathophysiology
of the various forms of LGMD.
In conclusion, this study presents new interacting
partners for LGMD proteins and other proteins known to
be involved in NMD. In this sense, it has the potential to
reveal new candidate genes for NMD but also modifiers of
the phenotype. This broad dataset should also help to take
a step further towards the understanding of skeletal
muscle tissue. In particular, it will help to improve our
knowledge about the cellular functions and roles of NMD
proteins in the muscle cell and about their participation in
the diseases they trigger thereby speeding up the identifi-
cation of putative drug targets.
Additional files
Additional file 1: Table S1. Comprehensive list of PPI of the LGMD-
centered network. Column A: Bait gene symbol; Column B: GI number of
reference for bait sequence (the name of the protein is indicated in Table
S1) Additional file 2: Table S2; Columns C-D: HUGO Gene Nomenclature
Committee (HGNC) and Uniprot identifiers for the bait (mapped by
DAVID); Column E: Prey gene symbol; Column F: GI number of reference
for prey sequence; Column G: Genbank notes for prey protein; Columns
H-I: HGNC and Uniprot identifiers for the prey (mapped by DAVID);
Column J: PBS category (A to E) for the Y2H PPI; Column K: PPI belonging
to the HC network (Y=yes); Column L: Reciprocal hits in our experiment
(Y=yes); Column M: Pubmed ID for previously described PPI in mammals;
Column N: PPI experimentally validated by immunoprecipitation (IP_pos),
co-localisation assays (Coloc_pos) or proximity ligation assays
(Duolink_pos). The negative results are also indicated (_neg), Columns O-
Q: GO annotation for pairs of proteins sharing a BP, CC and MF cluster,
respectively; Column R: Shared NMD associated with the prey protein;
Column S: OMIM of the associated NMD.
Additional file 2: Table S2. Comprehensive bait and Y2H screenings
information. a) Interaction was reciprocally found (A<->B) (b) TTN novex-
3 variant was found as prey.
Additional file 3: Table S3. List of SIDs. Column A: PBS category;
Column B: Bait gene symbol; Column C: Bait GI number; Columns D-E:
HGNC and Uniprot identifiers for the bait (mapped by DAVID; Column F:
Bait coordinates (aa) on the gi sequence translated product; Column G:
Prey gene symbol; Column H: Prey GI number; Columns I-J: HGNC and
Uniprot identifiers for the prey (mapped by DAVID); Columns K-L: SID
coordinate on the prey gi sequence translated product (first and last aa,
respectively); Column M-O: For PPIs from the PBS-A, -B and -C categories,
Interpro domains including the SID, included within the SID or
overlapping with the SID, respectively.
Additional file 4: Table S4. Human diseases associated with the
proteins of the network. Column A: Gene symbol; Column B: GI number
of the bait or prey sequence; Column C: Human genetic conditions
associated with the protein; Column D: OMIM number (ND= not
defined); Column E: Classification as NMD (Y=yes, N=no); Column F:
Classification of NMD according to the Neuromuscular Disorders Online
Gene Table (http://www.musclegenetable.fr) 1 Muscular dystrophies, 2
Congenital muscular dystrophies, 3 Congenital myopathies, 4 Distal
myopathies, 5 Other myopathies, 6 Myotonic syndromes, 7 Ion channel
muscle diseases, 8 Malignant hyperthermia, 9 Metabolic myopathies, 10
Hereditary cardiomyopathies, 11 Congenital myasthenic syndromes, 12
Spinal muscular atrophies, 13 Hereditary ataxia, 14 Hereditary motor and
sensory neuropathies, 15 Hereditary paraplegia, 16 Other NMD.
Additional file 5: Figure S1. Diseases related-protein network. NMD-
related proteins are depicted as blue node ovals and non-NMD-related
proteins are depicted as yellow node ovals. Interactions between pairs of
disease-related proteins are depicted by edges with colors according to
the PBS category (PBS-A: red, PBS-B: dark blue, PBS-C: green, PBS-D: light
blue, PBS-E: light pink). Only proteins that show interactions with
diseases-related proteins are presented.
Additional file 6: Table S5. List of PPIs for the literature-based network.
Column A: Gene symbol for the protein of the interactome; Columns B-C:
Gene symbol and HGNC identifier for the interacting partner from the Intact
database or the interactome; Column D: Name of the interacting partner.
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